RankingsPricing
  1. JP-listed companies
  2. Daito Pharmaceutical Co., Ltd.
  3. Financials
  4. Repayments of term debt

Daito Pharmaceutical Co., Ltd.【JP:4577】

Market cap
¥41B
P/E ratio
17.8x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRepayments of term debt (Million JPY)YoY (%)
May 31, 2025-3,099+52.74%
May 31, 2024-2,029+23.87%
May 31, 2023-1,638+13.43%
May 31, 2022-1,444-15.68%
May 31, 2021-1,712-7.53%
May 31, 2020-1,852-9.15%
May 31, 2019-2,039-10.01%
May 31, 2018-2,265-3.00%
May 31, 2017-2,335-10.94%
May 31, 2016-2,622-0.37%
May 31, 2015-2,632

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)